Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Sep 2015 Biomarkers information updated
- 21 Oct 2013 Planned End Date changed from 1 Jun 2014 to 1 May 2014 as reported by ClinicalTrials.gov.
- 27 Aug 2013 Planned end date changed from 1 Sep 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov.